Form 10-Q · Quarterly report
Sherwin-Williams 10-Q, filed Oct 27, 2026
- Filed
- CIK
- 0000089800
- Accession no.
- 0000089800-26-000056
Summary
Sherwin-Williams reported third-quarter 2026 net sales of $6.86 billion, up 7.9% from a year earlier, and income before income taxes of $1.06 billion, essentially flat versus the prior-year period. Consolidated gross profit as a percent of net sales fell to 47.8% from 49.2%, pressured by mix including dilution from the October 2025 Suvinil acquisition and higher raw material and supply chain costs.
Key points
- Nine-month 2026 net sales rose 7.4% to $19.32 billion, and nine-month income before income taxes rose to $2.86 billion from $2.70 billion.
- Consumer Brands Group third-quarter net sales rose 21.7% to $937.4 million, driven largely by the Suvinil acquisition, favorable currency translation and mix, partly offset by soft North American demand.
- Paint Stores Group third-quarter net sales rose 4.7% to $4.02 billion on selling price increases and low-single-digit volume growth, with same-store sales up 3.9%.
- Performance Coatings Group third-quarter net sales rose 8.8% to $1.90 billion, led by double-digit growth in General Industrial, Packaging and Coil.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. MANAGEMENT’S DISCUSSION RESULTS OF OPERATIONS The Company has historically experienced, and expects to continue to experience, variability in quarterly results. The results of operations for the three and nine months ended September 30, 2026 are not indicative of the results to be expected for the full year as our business is seasonal in nature, with the majority of Net sales traditionally occurring during the second and third quarters. However, periods of economic uncertainty can alter the Company’s seasonal patterns. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.